News
Updates about Leica Biosystems.
[DEER PARK, Ill. — June 9, 2026] — Leica Biosystems, a Danaher company and a global leader in end to end anatomic and digital pathology solutions, is advancing how pharmaceutical organizations scale digital and computational pathology to support AI enabled biomarker discovery and companion…
Designed to adapt to diverse biopharma development needs, and enabled by close collaboration and parallel execution, the partnership introduces a flexible global framework for companion diagnostic development intended to support more efficient progression from early-stage assays to commercial…
The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer Newcastle, United Kingdom — May 29, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital…
Vista, CA — May 28, 2026 Leica Biosystems, a Danaher company and global leader in anatomic and digital pathology solutions, today announced the availability of the Aperio HALO AP image management system (IMS) in Canada. The platform is designed to streamline digital pathology workflows by…
Expanding access to integrated AI tools helps pathologists tackle complex workflows and improve insights Lyon, France and VISTA, CA — May 27, 2026 DiaDeep, a Lyon-based company specialized in medical AI for oncology pathology, and Leica Biosystems, a Danaher company and a global leader in end…
VISTA, California — March 19, 2026 — Leica Biosystems, a Danaher company and a global leader in digital and anatomic pathology solutions, announces major expansion of the Aperio AI Store, reinforcing its momentum as a rapidly growing gateway to a curated menu of leading AI tools, seamlessly…